Taylor Wessing advises Accel and Meritech on USD 180 million Series C Funding Round of n8n

Berlin-based n8n, one of Europe’s leading providers of AI-powered process automation, has raised USD 180 million in a Series C funding round. The round was led by Accel, with Meritech, Redpoint, Evantic and Visionaries Club, NVentures (NVIDIA’s venture capital arm) and T.Capital also joining the round, and existing backers including Felicis Ventures, Sequoia, Highland Europe and HV Capital participating. A Taylor Wessing team, led by Berlin partner and VC growth expert Dr Norman Röchert, provided comprehensive legal advice to Accel and Meritech on all aspects of the transaction.

Since its founding in 2019, n8n has evolved from a workflow automation tool into a platform for AI orchestration and cross-team collaboration. Designed for orchestration and coordination, n8n connects agents to tools, data, and people in one platform, enabling AI, code, and humans to work together in production.

Accel is a global venture capital firm that is the first partner to exceptional teams everywhere, from inception through all phases of private company growth. For over 40 years, Accel has helped ambitious entrepreneurs build iconic global businesses.

Meritech is a venture capital firm founded in 1999 focusing on later-stage investments in information technology companies with a focus on internet and media, software and services, enterprise infrastructure, and medical devices.

Legal advisors to Accel and Meritech

Taylor Wessing Germany: Lead Dr Norman Röchert (Partner), Dr Anna Hankings-Evans (Senior Associate), Jasmin Bechtold (Associate), Felix Paul (Professional Support Lawyer), all Corporate M&A/Venture Capital, Berlin; Dr Gregor Schmid (Partner), Caroline Bunz (Associate), both Technology, Media & Telecoms, Berlin; Nico Jänicke (Partner), Sachka Stefanova-Behlert (Salary Partner), Sabrina Dettmer (Associate), all Employment, Berlin; Dr Nicolai Wiegand (Partner, IT, Munich); Arno Maria Gotting (Salary Partner, Frankfurt), Jan-Henrik Ellinghaus (Associate, Munich), both Commercial; Dr Michael Brüggemann (Partner), Malke Kristina Zimmermann (Associate), both Regulatory, Düsseldorf